It's not exactly uplifting, but this article from the Wall Street Journal reports on the fate of the pharmaceutical industry. (We'd say it places it somewhere between "embattled" and "dire.") While a number of blockbuster drugs are coming off patent, fewer and fewer drugs have gone on the market, and -- at least according to pharma execs -- FDA is getting increasingly picky about handing out approvals. None of this is news to GTO readers, of course, but it is a well researched article and has this as a virtue: it predicts that pharma salvation will lie in biotech innovation.
Â